|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
2413670 |
| 003 |
ICU |
| 005 |
20030521072200.0 |
| 008 |
960215s1994 wiua b 001 0 eng c |
| 010 |
|
|
|a 93039744
|
| 020 |
|
|
|a 0299140709 :
|c $40.00
|
| 035 |
|
|
|a (ICU)BID21597788
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OrLoB-B
|d OCoLC
|
| 041 |
0 |
|
|a eng
|
| 050 |
0 |
0 |
|a RC280.B8
|b L57 1994
|
| 060 |
|
0 |
|a WP 870 L857 1994
|
| 082 |
0 |
0 |
|a 616.99/449061
|2 20
|
| 245 |
0 |
0 |
|a Long-term tamoxifen treatment for breast cancer /
|c edited by V. Craig Jordan.
|
| 260 |
|
|
|a Madison, Wis. :
|b University of Wisconsin Press,
|c c1994.
|
| 300 |
|
|
|a xix, 289 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t The Development of Tamoxifen for Breast Cancer Therapy /
|r V. Craig Jordan --
|g 2.
|t Clinical Pharmacology and Endocrinology of Long-Term Tamoxifen Therapy /
|r Susan M. Langan Fahey, V. Craig Jordan, Nancy F. Fritz, Simon P. Robinson, David Waters and Douglass C. Tormey --
|g 3.
|t Multisystem Biological and Symptomatic Toxicity of Tamoxifen in Postmenopausal Women /
|r Richard R. Love --
|g 4.
|t Endocrine Therapy for the Premenopausal Woman /
|r R. W. Blamey --
|g 5.
|t The Nolvadex Adjuvant Trial Organisation (NATO) and the Cancer Research Campaign (CRC) Trials of Adjuvant Tamoxifen Therapy /
|r J. Houghton, D. Riley and M. Baum --
|g 6.
|t The Stockholm Adjuvant Tamoxifen Trial /
|r Lars E. Rutqvist --
|g 7.
|t Maintenance Tamoxifen after Induction Postoperative Chemotherapy in Node-Positive Breast Cancer Patients /
|r D. C. Tormey, R. Gray, H. C. Falkson, K. Gilchrist, M. D. Abeloff and G. Falkson /
|r participating investigators --
|g 8.
|t Prolonged Tamoxifen Treatment of Early Breast Cancer: The Experience of the Italian Cooperative Group for Chemohormonal Therapy of Early Breast Cancer /
|r Francesco Boccardo, Domenico Amoroso, Alessandra Rubagotti, Mario Capellini, Paolo Pacini, Luigi Castagnetta, Adele Traina, Antonio Farris, Stefano Iacobelli, Giorgio Mustacchi, Italo Nenci, Adriano Piffanelli, Piero Sismondi, Corrado De Sanctis, Mario Mesiti, Luigi Gallo, Eugenio Villa and Guiseppe Schieppati /
|r other participants in the GROCTA studies --
|g 9.
|t Interactions of Tamoxifen with Cytotoxic Chemotherapy for Breast Cancer /
|r C. K. Osborne --
|g 10.
|t Tamoxifen-Resistant Growth /
|r Douglas M. Wolf, Marco M. Gottardis and V. Craig Jordan --
|g 11.
|t A New Approach to Breast Cancer Therapy - Total Estrogen Ablation with Pure Antiestrogens /
|r A. E. Wakeling --
|g 12.
|t Symptomatic Side Effects of Tamoxifen Therapy /
|r Michael Fritsch and Douglas M. Wolf --
|g 13.
|t The Prevention of Breast Cancer with Tamoxifen /
|r Monica Morrow and V. Craig Jordan.
|
| 650 |
|
0 |
|a Tamoxifen.
|0 http://id.loc.gov/authorities/subjects/sh85132219
|
| 650 |
|
0 |
|a Breast
|x Cancer
|x Chemotherapy.
|0 http://id.loc.gov/authorities/subjects/sh2009117562
|
| 650 |
|
2 |
|a Breast Neoplasms
|x drug therapy.
|
| 650 |
|
2 |
|a Tamoxifen.
|
| 650 |
|
7 |
|a Breast
|x Cancer
|x Chemotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00838266
|
| 650 |
|
7 |
|a Tamoxifen.
|2 fast
|0 http://id.worldcat.org/fast/fst01142573
|
| 700 |
1 |
|
|a Jordan, V. Craig
|q (Virgil Craig)
|0 http://id.loc.gov/authorities/names/n82057300
|1 http://viaf.org/viaf/64260372
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 035 |
|
|
|a (OCoLC)29185180
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i daf8154d-d13f-56c6-9dd6-fc5f97aab384
|s e0fc75a0-a414-504d-bb93-da41cc6811e7
|
| 928 |
|
|
|t Library of Congress classification
|a RC280.B8L570 1994
|l ASR
|c ASR-SciASR
|i 6031587
|
| 927 |
|
|
|t Library of Congress classification
|a RC280.B8L570 1994
|l ASR
|c ASR-SciASR
|e CRERAR
|b 42936627
|i 4568902
|
